Live feed
·
SECFilingvia Quantisnow
First Tracks Biotherapeutics Inc. logo

TRAXV: First Tracks Biotherapeutics Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Material Modification to Rights of Security Holders, Entry into a Material Definitive Agreement, Changes in Control of Registrant, Other Events

ByQuantisnow·Wall Street's wire, on your screen.
Stocks in this Quantisnow insight
Quantisnow market dataNASDAQ
First Tracks Biotherapeutics Inc. logo
TRAXV
First Tracks Biotherapeutics Inc.
Market cap
30-day
Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Get push alerts for TRAXV

Follow TRAXV and get a push notification the moment its next story breaks.

Full TRAXV profile on Quantisnow
Original source Picked up and delivered by Quantisnow in real time

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TRAXV (First Tracks Biotherapeutics Inc.) and more on Quantisnow.

TRAXV: First Tracks Biotherapeutics Inc. filed SEC Form 8-K...